Pfizer CEO Albert Bourla says uncertainty around President Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development.
Comments
Log in with your Bluesky account to leave a comment
Albert Bourla appears to be seeking dismissal from Pfizer's board of directors if he isn't prepared for the new challenges that his resignation presents.
Comments